Critical Therapeutics, Inc. (NASDAQ: CRTX) will conduct a conference
call at 5:00 p.m. (EDT) on Thursday, May 8, following the release of its
first quarter 2008 financial results. Critical Therapeutics’
Chief Executive Officer, Trevor Phillips, will lead the call, during
which management will discuss the Company’s
first quarter 2008 financial results and recent corporate activities.
Investors and others are invited to listen live via telephone or the
Internet.
What:
Critical Therapeutics First Quarter 2008 Financial Results
Conference Call
When:
5:30 p.m. (EDT) Thursday, May 8, 2008
Dial-in:
From the U.S. and Canada, dial (877) 709-8155
International callers, dial (201) 689-8881
Webcast:
Visit www.crtx.com, select
"Investors" and then click on the conference call link.
Replay:
Visit www.crtx.com, select
"Investors" and then "Webcasts & Presentations."
About Critical Therapeutics
Critical Therapeutics, Inc. is developing and commercializing innovative
products for respiratory, inflammatory and critical care diseases.
Critical Therapeutics owns worldwide rights to two FDA-approved drugs:
twice-daily ZYFLO CR™ (zileuton)
extended-release tablets and ZYFLO® (zileuton
tablets). Critical Therapeutics is developing products for acute asthma
attacks that lead patients to the emergency room and other urgent care
settings. Critical Therapeutics also is developing therapies directed
toward the body’s inflammatory response.
Critical Therapeutics is located in Lexington, Mass. For more
information, please visit www.crtx.com.
|